Drugs, part 1: can we trust Big Pharma?

Seeking to replace Warfarin as a blood thinner, Duke Clinical Research Institute ran a trial that ended with approval of the drug Xarelto. However, later the blood testing device malfunctioned. Duke did further tests and published a letter in the New England Journal of Medicine saying that the problems with the machine did not affect …

Continue reading ‘Drugs, part 1: can we trust Big Pharma?’ »